||The topic of this article may not meet Wikipedia's general notability guideline. (February 2017) (Learn how and when to remove this template message)|
|Industry||Healthcare, Personal Genomics|
|Founder||Brandon Colby, MD|
|Headquarters||Los Angeles, California, U.S.|
|Brandon Colby, MD, MBA - CEO & Medical Director|
|Services||Genetic testing, analysis and reporting services of humans and animals|
|Website||http://www.existencegenetics.com/ (NOT ACTIVE, Updated: 02-JUN-2013)|
Existence Genetics was a genetic analysis and genetic reporting company that was founded in 2005 and declared bankruptcy on November 21, 2012.
The company used the Nexus DNA Chip, which was developed in-house, manufactured by Illumina, and run in a CLIA-certified laboratory in the USA. The Nexus DNA Chip was purported to test for thousands of clinically significant SNPs, DIPs, and CNVs, and be able to assess a person’s risk of over 700 common and rare diseases.
In October 2010 Existence sued Wilson Sonsini for fraud and breach of contract concerning the law firm's representation of Existence in patent prosecution and over fund-raising advice.
In October 2011, Existence announced an upgrade to their genetic testing and analysis capabilities that they claimed allowed them to test for over 1,200 diseases, conditions, traits, and medication reactions.
- Pete Brush for Law360, October 18, 2010. Existence Genetics Hits Wilson Sonsini With Fraud Suit
- Staff, Bloomberg BusinessWeek. Company Overview of Existence Genetics, LLC Accessed June 03, 2013
- Steve Parker. "Existence Genetics Ramps up for Widespread Test Service Launch, Eyes Whole-Genome Sequencing". GenomeWeb. Retrieved 2011-06-01.
- "Existence Genetics l Rare Disease Screen l Comprehensive Rare Disease Genetic Testing & Analysis". Existence Genetics. Retrieved 27 December 2011.
- Staff, business-bankruptcies.com. Existence Genetics, LLC bankruptcy information Accessed June 3, 2013